Insight Provider, CrossASEAN Research

Nicolas Van Broekhoven

Was on the buyside for 15 years, most recently at a medium-sized boutique asset management firm. I grew up in Europe, went to university in the US and have been living in Singapore for the last 7 years which has given me a broad scope on the world and investing in general.

Consider myself a generalist investor with a preference for small and mid-cap companies and special situations. However, a large cap that has gone temporarily out of favor might also pique my interest. 

My style of investing could be categorized as more of value investor, rather than growth at any cost. Learning from Charlie Munger on the importance of quality of a company has been of tremendous value over the years.I like businesses with real earnings, cash flows, dividends, book value and insider ownership.

Insight Provider

Oriental Watch: Increasing Visibility on H2 2022

Oriental Watch: Good Results in the Bag, Cautious H1 2023

Oriental Watch Update: June and July Improve, Cautious H1 FY23

Oriental Watch: Buying a Rolex in Milan or New York? No, Thanks We Will Get It in Shanghai & Beijing

Oriental Watch: Great 0.39 HKD Final Dividend; With China Closed off from World Expect More of Same

Oriental Watch - Expect a Positive Profit Alert for H1

Oriental Watch: Sit Tight and Stay On For Larger Dividends

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

<ul>
<li>Oriental Watch's 1H22 results again demonstrate the company remains a prime beneficiary of <strong>China's isolationist zero-Covid policy</strong>. Revenues +36.8% and Profits +188% YoY. Net Margin of 9% highest ever achieved.</li>
<li>With no outbound Chinese tourism allowed, the internal consumption of luxury watches remains strong. Worldwide shortages of Rolex and Patek Philippe watches drive higher ASP  enhancing margins.</li>
<li>Rock-Solid balance sheet and high dividend payout as reliable as a Swiss Watch. Stock up +110% YTD but the company is still on a 13% annual dividend yield.</li>
</ul>


Oriental Watch's 1H22 results again demonstrate the company remains a prime beneficiary of China's isolationist zero-Covid policy. Revenues +36.8% and Profits +188% YoY. Net Margin of 9% highest ever achieved.
With no outbound Chinese tourism allowed, the internal consumption of luxury watches remains strong. Worldwide shortages of Rolex and Patek Philippe watches drive higher ASP  enhancing margins.
Rock-Solid balance sheet and high dividend payout as reliable as a Swiss Watch. Stock up +110% YTD but the company is still on a 13% annual dividend yield.


Oriental Watch: Living in Isolation with My Patek and Rolex Is Just Fine